Stents Drug Eluting

 PLATINUM DIVERSITY, stents in minorities and women
News | Cath Lab | November 09, 2016

November 9, 2016 — A dedicated stent study conducted exclusively in women and minority patients evaluated clinical...

Videos | Stents Bioresorbable | November 09, 2016

Juan Granada, M.D., executive director and chief scientific officer of the Cardiovascular Research Foundation's...

Biotronik's Osiro stent, prison IV trial

Biotronik's Osiro ultra-thin strut, sirolimus-eluting stent.

News | Stents | November 09, 2016

November 9, 2016 – Results from a randomized, multicenter trial failed to show non-inferiority of hybrid, ultra-thin...

Videos | Cath Lab | November 08, 2016

David Kandzari, M.D., director of interventional cardiology and chief scientific officer, Piedmont Heart Institute,...

OCT stent strut coverage

OCT imaging showing neointimal tissue coverage of metallic stent struts.

News | Stents | November 07, 2016

November 7, 2016 – Results from TRANSFORM-OCT, a prospective, randomized trial using optical coherence tomography (...

biosensors Biofreedom stent
News | Stents | November 07, 2016

November 7, 2016 – The two-year results from LEADERS FREE, the first randomized clinical trial dedicated to high...

Bionics trial, Medinol, BioNIR stent, elastic polymer

Imaging of stent struts after expansion, showing the elastic polymer used on Medinol’s BioNIR stent does not crack or flake off, possibly leading to better patient outcomes. 

News | Stents | November 07, 2016

November 7, 2016 – The large multinational randomized BIONICS study found that a novel elastic polymer coated...

Medtronic, Resolute Integrity DES, drug-eluting stent, BIO-RESORT study, TCT 2016
News | Stents Drug Eluting | November 02, 2016

November 2, 2016 — Investigators recently unveiled clinical data from the independent BIO-RESORT study, representing...

Medtronic, Drug-Filled Stent, DFS, RevElution trial, first clinical data, TCT 2016, Stephen Worthley
News | Stents Drug Eluting | November 01, 2016

November 1, 2016 — Medtronic plc unveiled the first clinical outcomes of its novel...

News | Stents Drug Eluting | October 31, 2016

October 31, 2016 — Micell Technologies Inc. announced that it presented five-year clinical safety and efficacy...

EXCEL Trial, TCT 2016, drug-eluting stents, CABG, surgery left main heart disease, LMCAD
Feature | Stents Drug Eluting | October 31, 2016

October 31, 2016 — A major international study has found that...

TCT 2016, TCT.16, main arena, late breaking trials
Feature | Cath Lab | September 28, 2016

September 28, 2016 — The Cardiovascular Research Foundation (CRF) has announced the 11 late-breaking trials and 16...

Gore, Tigris stent, fluoropolymer nitinol stent, peripheral artery disease

The Gore Tigris is a dual-component stent with a unique fluoropolymer / nitinol design.

Technology | Stents Peripheral | August 02, 2016

August 2, 2016 —The U.S. Food and Drug Administration (FDA) granted market clearance for W. L. Gore & Associates...

Biotronik, ORIENT trial results, EuroPCR 2016, Orsiro DES, hybrid drug-eluting stent
News | Stents Drug Eluting | June 03, 2016

June 3, 2016 — Biotronik announced results establishing non-inferiority of the Orsiro hybrid...

Biosensors' Biomatrix stent.

Feature | Stents | May 16, 2016

May 16, 2016 — Cardinal Health announced it has entered into a distribution agreement with Biosensors that enables...

Overlay Init